Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague

被引:25
作者
Heine, Henry S.
Louie, Arnold
Sorgel, Fritz
Bassett, Jennifer
Miller, Lynda
Sullivan, Lawrence J.
Kinzig-Schippers, Martina
Drusano, George L.
机构
[1] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA
[2] Ordway Res Inst, Albany, NY USA
[3] Inst Biomed & Pharmaceut Res, Nurnberg, Germany
关键词
D O I
10.1086/520547
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction. Intentional release of Yersinia pestis will likely be propagated by aerosol exposure. We explored the effects of neutropenia on the outcome of doxycycline and gentamicin therapy. Methods. Female BALB/c mice were exposed to 20 LD50 of Y. pestis CO92 by aerosol. Treatments were saline (negative control), levofloxacin at 15 mg/kg every 12 h (positive control), doxycycline at 40 mg/kg every 6 h, and gentamicin at 12 mg/kg every 6 h, 24 mg/kg every 12 h, and 48 mg/kg every 24 h in cohorts of normal and neutropenic mice for 5 days. Results. Control mice died. Positive control mice ( levofloxacin) had 100% survivorship in both neutropenic and nonneutropenic groups. Doxycycline treatment in the presence of granulocytes yielded 90% survivorship; all neutropenic mice died after the termination of treatment (P << .001). For gentamicin, survivorship of mice receiving drug every 24, 12, and 6 h was, respectively, 80%, 80%, and 90% for normal mice and 80%, 100%, and 70% for neutropenic mice. No significant differences were seen in the neutropenia versus normal mouse comparison or by schedule. Conclusions. Doxycycline behaves in vivo as a bacteriostatic drug, requiring an intact immune system for clearance of the infection after aerosol challenge with Y. pestis. Gentamicin is bactericidal, even when given on a daily schedule. Neutropenia did not significantly affect survivorship.
引用
收藏
页码:782 / 787
页数:6
相关论文
共 20 条
[1]  
[Anonymous], 1926, TREATISE PNEUMONIC P
[2]  
[Anonymous], 2002, PHARMACOTHERAPY
[3]  
BOEHR DD, 2003, ANTIBIOTIC CHEOTHERA, P163
[4]  
BUTLER T, 2000, PRINCIPLES PRACTICE, P2406
[5]   Antibiotic treatment of experimental pneumonic plague in mice [J].
Byrne, WR ;
Welkos, SL ;
Pitt, ML ;
Davis, KJ ;
Brueckner, RP ;
Ezzell, JW ;
Nelson, GO ;
Vaccaro, JR ;
Battersby, LC ;
Friedlander, AM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) :675-681
[6]   Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses [J].
Chien, SC ;
Rogge, MC ;
Gisclon, LG ;
Curtin, C ;
Wong, F ;
Natarajan, J ;
Williams, RR ;
Fowler, CL ;
Cheung, WK ;
Chow, AT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (10) :2256-2260
[7]  
*CLIN LAB STAND I, 2005, METH DIL ANT SUSC TE
[8]   CAT-TRANSMITTED FATAL PNEUMONIC PLAGUE IN A PERSON WHO TRAVELED FROM COLORADO TO ARIZONA [J].
DOLL, JM ;
ZEITZ, PS ;
ETTESTAD, P ;
BUCHOLTZ, AL ;
DAVIS, T ;
GAGE, K .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1994, 51 (01) :109-114
[9]  
EDBERG SC, 1986, ANTIBIOTICS LAB MED, P382
[10]   QUANTITATIVE ASSOCIATION BETWEEN ELECTRICAL POTENTIAL ACROSS THE CYTOPLASMIC MEMBRANE AND EARLY GENTAMICIN UPTAKE AND KILLING IN STAPHYLOCOCCUS-AUREUS [J].
EISENBERG, ES ;
MANDEL, LJ ;
KABACK, HR ;
MILLER, MH .
JOURNAL OF BACTERIOLOGY, 1984, 157 (03) :863-867